Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
autoimmune diseases
bill &
biotech ipos
cancer
clinical trials
democrats
drug price
immunotherapy
investing
medicaid
nancy pelosi
negotiation
What
plan
drug
house
market
new
advantages
anathema
answer
arrival
awaited
away
bar
bio
biotech
brings
companies
days
democrat
democratic
dems
details
discontent
drugs
election
elements
expect
gamble
hasn’t
high
industry
ipo
ipos
leaked
life
long
look
lower
medco’s
momentum
monday
Language
unset
4
×
Current search:
medicare
×
unset
×
" boston blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
